Goldstein Market
Date of publication: 31 March 2020
Emergency Contraceptive Pills (ECP) Market is Expected to Garner $ 1.25 Billion by 2024
According to Goldstein Market Intelligence, Global emergency contraceptive pills market is expected to reach USD 1.25 billion by the end of 2024.
According to Goldstein Market Intelligence, Global emergency contraceptive pills market is expected to reach USD 1.25 billion by the end of 2024, growing at a CAGR of 1.89% over the forecast period through 2024. The government initiatives programs to curb the expenses on unwanted abortions are majorly driving the growth of global ECP market. Global Emergency contraceptive pills market segmentation has been done on the basis of EC pill type, sales channel and geography. Based on EC pill type, Progesterone Pills accounted for largest market share of 40% in 2016 and this tends to remain the dominating segment over the forecast period.
 
Global Emergency contraceptive pills market is dominated by North America with 40% market share in 2016. Asia-Pacific region is growing at a CAGR of 1.91% over the forecast period. Latin America and South Africa are among the top lucrative market for the growth of ECP market.
 

Market Segmentation

On the basis of our in-depth analysis, Global Emergency Contraceptive Pills Market can be segmented as follows:

By EC Pill Type

  • Combination Pills
  • Progesterone Pills
  • Estrogen Pills
  • Other Products

By Sales Channel

  • Drug Stores/ Pharmacy
  • Hospital Pharmacies
  • Online Traders
  • Other Channels

On the basis of region

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
  • Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
 
Request for Sample Request @ https://www.goldsteinresearch.com/request-sample/global-emergency-contraceptive-pills-ecp-market-size
 
“Global Emergency Contraceptive Pills Market Outlook 2024” by Goldstein Market Intelligence contains detailed overview of the Global Emergency contraceptive pills market in terms of market segmentation by EC pill type and distribution channel.
 
Further, Global Emergency Contraceptive Pills Market SizeReport encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Allergan, Lupin, Mankind, Piramal, Teva, Bayer AG, HLL Life Care, Pfizer, Syzygy Healthcare, V Care Pharma, HRA Pharma, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co., etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
 
 Overall, the report represents the Global Emergency contraceptive pills market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
 
The Report is Available @ https://www.goldsteinresearch.com/report/global-emergency-contraceptive-pills-ecp-market-size
 

About Goldstein Research

 
Based in the US, Goldstein Market Intelligence currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
 
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of Global and regional variations along with competitors’ overview.
 
Our analysts working on healthcare sector analysis reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.
 
Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada:  1-437-886-1181
UK: +44-203-318-6627
sales@goldsteinresearch.com
www.goldsteinresearch.com

Back to the list